HomeCompareSEMHF vs QYLD

SEMHF vs QYLD: Dividend Comparison 2026

SEMHF yields 2.05% · QYLD yields 11.92%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SEMHF wins by $3.7K in total portfolio value
10 years
SEMHF
SEMHF
● Live price
2.05%
Share price
$42.47
Annual div
$0.87
5Y div CAGR
19.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$29.1K
Annual income
$1,720.03
Full SEMHF calculator →
QYLD
Global X Nasdaq 100 Covered Call ETF
● Live price
11.92%
Share price
$17.15
Annual div
$2.04
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.4K
Annual income
$5,659.31
Full QYLD calculator →

Portfolio growth — SEMHF vs QYLD

📍 SEMHF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSEMHFQYLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SEMHF + QYLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SEMHF pays
QYLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SEMHF
Annual income on $10K today (after 15% tax)
$174.06/yr
After 10yr DRIP, annual income (after tax)
$1,462.03/yr
QYLD
Annual income on $10K today (after 15% tax)
$1,013.51/yr
After 10yr DRIP, annual income (after tax)
$4,810.41/yr
At 15% tax rate, QYLD beats the other by $3,348.39/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SEMHF + QYLD for your $10,000?

SEMHF: 50%QYLD: 50%
100% QYLD50/50100% SEMHF
Portfolio after 10yr
$27.2K
Annual income
$3,689.68/yr
Blended yield
13.55%
📊

Analyst Conviction Gap

Where Wall Street is split right now

SEMHF
Analyst Ratings
1
Hold
Consensus: Hold
Altman Z
1.9
Piotroski
7/9
QYLD
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SEMHF buys
0
QYLD buys
0
No recent congressional trades found for SEMHF or QYLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSEMHFQYLD
Forward yield2.05%11.92%
Annual dividend / share$0.87$2.04
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR19.7%0%
Portfolio after 10y$29.1K$25.4K
Annual income after 10y$1,720.03$5,659.31
Total dividends collected$7.7K$27.1K
Payment frequencyquarterlymonthly
SectorStockETF

Year-by-year: SEMHF vs QYLD ($10,000, DRIP)

YearSEMHF PortfolioSEMHF Income/yrQYLD PortfolioQYLD Income/yrGap
1← crossover$10,945$245.12$10,352$1,192.36+$593.00SEMHF
2$12,011$300.13$10,830$1,347.57+$1.2KSEMHF
3$13,221$368.46$11,460$1,539.07+$1.8KSEMHF
4$14,600$453.69$12,275$1,777.84+$2.3KSEMHF
5$16,182$560.49$13,323$2,078.95+$2.9KSEMHF
6$18,010$694.97$14,667$2,463.34+$3.3KSEMHF
7$20,136$865.27$16,396$2,960.57+$3.7KSEMHF
8$22,628$1,082.23$18,631$3,612.97+$4.0KSEMHF
9$25,572$1,360.50$21,548$4,482.15+$4.0KSEMHF
10$29,082$1,720.03$25,398$5,659.31+$3.7KSEMHF

SEMHF vs QYLD: Complete Analysis 2026

SEMHFStock

Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. It operates through four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment provides magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound systems. The Diagnostics segment offers in-vitro diagnostic products and services to healthcare providers in laboratory, molecular, and point-of-care diagnostics; and workflow solutions for laboratories and informatics products. The Varian segment provides cancer care technologies, and solutions and services to oncology departments in hospitals and clinics; and technology-enabled optimized workflows, clinical services and consulting capabilities, and digital solutions and applications for managing treatment and therapy. The Advanced Therapies segment offers products that are designed to support image-guided minimally invasive treatments in various areas, such as cardiology, interventional radiology, and surgery; and angiography systems and mobile C-arms, including a robotic-assisted platform for endovascular coronary and peripheral vascular interventions. It also provides equipment performance management, clinical education and e-learning, asset management, and managed departmental services for laboratories and healthcare facilities, as well as consulting and digital health services. The company is headquartered in Erlangen, Germany. Siemens Healthineers AG operates as a subsidiary of Siemens Aktiengesellschaft.

Full SEMHF Calculator →

QYLDETF

The Global X Nasdaq 100 Covered Call ETF (QYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Nasdaq-100 BuyWrite V2 Index.

Full QYLD Calculator →
📬

Get this SEMHF vs QYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SEMHF vs SCHDSEMHF vs JEPISEMHF vs OSEMHF vs KOSEMHF vs MAINSEMHF vs XYLDSEMHF vs JEPQSEMHF vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.